Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07355894 · ClinicalTrials.gov registry record · NA
Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 120,000
- Enrollment target
NCT07355894: Clinical Trial NA study, sponsored by Stanford University.
NCT07355894 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 120,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07355894, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 120,000 participants
- Enrollment target
Study Summary
This multi-site study will test whether an opportunistic AI-based CAC screening and notification intervention can improve cholesterol treatment and lower cholesterol levels in adults. The study uses artificial intelligence to detect calcium buildup in heart arteries (coronary artery calcium or CAC) on chest CT scans that patients have already had for other reasons. The study will focus on adults who either have known atherosclerotic cardiovascular disease (ASCVD) or have significant calcium buildup (a CAC score of 100 or higher), and whose cholesterol is not well controlled. It will also evaluate how well this approach can be implemented at scale across multiple health systems. The main questions it aims to answer are: Does notifying patients and their clinicians about incidental CAC increase lipid-lowering therapy(LLT) initiation or intensification? Does the intervention improve Low-Density Lipoprotein(LDL)-cholesterol control and related lipid testing? How does the intervention affect downstream care (e.g., clinic visits, cardiology referrals, and cardiac testing)? Researchers will use an FDA-cleared AI algorithm to quantify CAC on previously performed non-gated chest CT scans and identify eligible participants through the electronic health record. Participants will be randomized to receive CAC notification either right away or after a 6-month delay.
Interventions
- OTHER AI-Detected CAC Notification and Care Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120,000 participants |
| Start Date | 2026-05 |
| Est. Completion | 2028-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07355894
The ClinicalTrials.gov registry entry for NCT07355894 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 120,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AI-Detected CAC Notification and Care Facilitation is the first listed.
NCT07355894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07355894 about?
NCT07355894 is a clinical study titled "Health Enhanced Artery Risk Tracking With Widespread Implementation and Screening Effort in ASCVD (HEARTWISE-ASCVD)". This multi-site study will test whether an opportunistic AI-based CAC screening and notification intervention can improve cholesterol treatment and lower cholesterol levels in adults. The study uses artificial intelligence to detect calcium buildup in heart arteries (coronary artery calcium or CAC) ...
What is the current status of trial NCT07355894?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 120,000 participants. The study started on 2026-05. Estimated completion is 2028-03.
What interventions are being tested in trial NCT07355894?
The interventions under investigation include: AI-Detected CAC Notification and Care Facilitation (OTHER).
Who is sponsoring clinical trial NCT07355894?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.